[Scavenger receptor family and molecular mechanism of xenobiotic removal].
Ikemoto
M
M
Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033.
Arai
H
H
D000544:Alzheimer Disease / Q000209:etiology; D000818:Animals; D017209:Apoptosis; D001161:Arteriosclerosis / Q000209:etiology; D003920:Diabetes Mellitus / Q000209:etiology; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D008077:Lipoproteins, LDL / Q000378:metabolism; D008565:Membrane Proteins; D011971:Receptors, Immunologic / Q000145:classification / Q000378:metabolism; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D015262:Xenobiotics / Q000378:metabolism*
D017127:Glycation End Products, Advanced; D008077:Lipoproteins, LDL; D008565:Membrane Proteins; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; D015262:Xenobiotics; C099252:oxidized low density lipoprotein